Feasibility Analysis of Methylene Blue Positioning of Sentinel Lymph Node Detected by Contrast-Enhanced Ultrasonography for Breast Cancer

李志旺,于志强,孙德胜,韦伟,韩彬

DOI: https://doi.org/10.3969/j.issn.1004-0412.2012.13.014

2012-01-01

Abstract:Objective To explore the feasibility and value of the method of methylene blue positioning of sentinel lymph node detected by contrast-enhanced ultrasonography for breast cancer.Method26 patients with early stage breast cancer in our hospital were divided into two groups randomly.The study group consisted of 16 patients were intradermal and subcutaneous injection of 1.5 ml contrast agent in the area of areolar near the tumor side,observed the contrast enhancement of SLN,and then injected 0.1~0.2 ml methylene blue in the SLN under the guidance of ultrasound.The surface marked with a marker pen.Finally take out the SLN which marked with operation.The control group consisted of 10 patients which received a 2 ml subdermal injection of methylene blue in the areola after induction of anesthesia.Then find the blue-stained lymph node(SLN) along the lymphatic vessels running after 10~20 min.A standard axillary incision was made,and the SLN was send to routine pathological examination.ResultsIn the study group,the accuracy rate of SLN was 100%,no false negative,the control group′s accuracy rate was 88.9%,and there was 1 false negative,false negative rate was 20%.There was no statistical difference in two groups of various evaluation indexes(P0.05).ConclusionThe method of methylene blue positioning of sentinel lymph node detected by contrast-enhanced ultrasonography for breast cancer shows good results in its discovery rate,accuracy and sensitivity.It is one of the effective means of breast cancer sentinel lymph node biopsy.